Back to search

Article

Profiling of Driver Mutations Identified Rare Compound Mutations Sensitive to Second-generation EGFR-TKI in Lung Adenocarcinoma Patients

2022-11-15

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) is the most predominant histological subtype of lung cancer characterized by driver mutations detected in a substantial proportion of the cases. Tyrosine kinase inhibitors (TKIs) are standard care for the patients with these mutations. In this study, we evaluated the efficiency of an NGS-based 8-gene test in selecting TKIs-sensitive Chinese LUAD patients who are tre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4544d1b6-7fee-52be-a6d1-787eb1f36c84
DOI
10.21203/rs.3.rs-2242483/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Profiling of Driver Mutations Identified Rare Compound Mutations Sensitive to Second-generation EGFR-TKI in Lung Adenocarcinoma PatientsDOI 10.21203/rs.3.rs-2242483/v1
Select a neighboring publication to make it the new centre.